Targeting of a Mutant Plasminogen Activator to Circulating Red Blood Cells for Prophylactic Fibrinolysis-Reference-Cited by-同舟云学术

Targeting of a Mutant Plasminogen Activator to Circulating Red Blood Cells for Prophylactic Fibrinolysis

Published:2009-12-01 Issue:3 Volume:332 Page:1022-1031
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Zaitsev Sergei,Spitzer Dirk,Murciano Juan-Carlos,Ding Bi-Sen,Tliba Samira,Kowalska M. Anna,Bdeir Khalil,Kuo Alice,Stepanova Victoria,Atkinson John P.,Poncz Mortimer,Cines Douglas B.,Muzykantov Vladimir R.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference39 articles.

1. Humanization of antibodies;Almagro;Front Biosci,2008

2. Red Blood Cells-Coupled tPA Prevents Impairment of Cerebral Vasodilatory Responses and Tissue Injury in Pediatric Cerebral Hypoxia/Ischemia through Inhibition of ERK MAPK Activation

3. CR1 and CR1-like: the primate immune adherence receptors

4. Comparison of TNK with wild-type tissue plasminogen activator in a rabbit embolic stroke model;Chapman;Stroke,2001

5. Fibrin-Selective Thrombolytic Therapy for Acute Myocardial Infarction

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering of Erythrocytes as Drug Carriers for Therapeutic Applications;Advanced Biology;2024-07-22

2. Drug-loaded erythrocytes: Modern approaches for advanced drug delivery for clinical use;Heliyon;2024-01

3. In situ cellular hitchhiking of nanoparticles for drug delivery;Advanced Drug Delivery Reviews;2024-01

4. A brief history of long circulating nanoparticles;Advanced Drug Delivery Reviews;2022-09

5. Surface Modification of Erythrocytes with Lipid Anchors: Structure–Activity Relationship for Optimal Membrane Incorporation, in vivo Retention, and Immunocompatibility;Advanced NanoBiomed Research;2022-07-19